ClinicalTrials.gg
RecruitingNCT07523113Updated Oct 29, 2026

ME/CFS Brain Fog: Cognitive Rehabilitation Trial

An interventional study of Processing Speed Training and In-session Instrumental Activities of Daily Living Training in ME/CFS, ME/CFS Following EBV-associated Infectious Mononucleosis and ME/CFS Following COVID-19, sponsored by University of Alabama at Birmingham. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 86 studies in Fatigue Syndrome, Chronic with a site in United States — 21 open to participants now, 24 under way, none of them phase 3. Fatigue Syndrome, Chronic · United States.

Planned enrollment
38th of 58
30 · median 50
Started
2026
with 6 others
No phase
30 of 86
6 open now
Primary completion
2027-06
later than 12 of 23 live
Registered
82nd of 86
by date
Lead sponsor
5 of 86
University of Alabama at Birmingham

Among the 86 studies in Fatigue Syndrome, Chronic with a site in United States, this one is the 38th largest by planned enrollment of the 58 interventional ones that give a count, is one of 7 that started in 2026, is one of 30 with no phase, reaches primary completion later than 12 of the 23 other live ones, and was the 82nd registered.

Fatigue Syndrome, Chronic

265 studies on the registry are indexed under Fatigue Syndrome, Chronic; 63 are open to participants now.

Browse Fatigue Syndrome, Chronic studies →

Open to participants now

21 of the 86 studies in Fatigue Syndrome, Chronic with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 45 Fatigue Syndrome, Chronic studies recruiting now, 19 (42%) set no upper age limit and 20 (44%) stop at 75 or younger; 5 take children under 18; 10 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 86 studies in Fatigue Syndrome, Chronic with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to compare two approaches to cognitive rehabilitation in adults with post-viral cognitive syndrome, which resulted in brain fog. All participants will be screened for eligibility prior to participation. Most of the procedures will take place over a phone call or secure telehealth platform (i.e., Zoom). However, participants will be asked to visit UAB on three occasions for blood sample collection and brain imaging (about 2 hours each). Online testing will happen one month before treatment, one day before treatment, one day afterwards, and 6 months afterwards. The study will utilize two different forms of rehabilitation training to improve participants' cognitive ability. Participants will be randomized to one of the two treatment groups. The first treatment approach, known as Constraint-Induced Cognitive Therapy (CICT), will feature (A) web-based computer "games" that trains how quickly individuals process information that they receive through their senses; (B) online training on everyday activities with important cognitive components, (C) procedures designed to transfer improvements in cognition from the treatment setting to everyday life, and (D) a non-invasive form of vagus nerve stimulation, also known as trans-auricular VNS (taVNS). The second approach, known as Brain Fitness Training (BFT), will include (A) web-based computer "games" that train reaction time and eye-hand coordination; (B) in-lab training on relaxation, breathing, healthy nutrition, and healthy sleep, (C) education about how relaxation, breathing, nutrition, and sleep are connected to thinking effectiveness, and (D) taVNS. Approximately 30 hours of training will be conducted over a secure telehealth platform (i.e., Zoom) in the span of two- to four- weeks. A typical CICT session will consist of one hour of gaming, with the bulk of the session being spent on cognitive training of the target behaviors and procedures designed to promote transfer of therapeutic gains to daily life. ta-VNS will be administered for 10 minutes before gaming and in-lab target behavior training. A typical BFT session will consist of one hour of gaming, training on healthy lifestyle behaviors (i.e., healthy sleep, nutrition, and relaxation habits), as well as procedures designed to promote transfer of behavior changes to daily life. Ta-VNS will be administered for 10 minutes before gaming and in-lab target behavior training. Training sessions in both conditions will be scheduled based on participants' availability, with the options for sessions scheduled to be as close as every weekday over 2 weeks or as loosely as every other weekday (i.e., over a 4-week span). If a caregiver is available, they will receive training on how to best support participants in their therapeutic program. After the training ends, both groups will receive 4 follow-up phone calls approximately one week apart to promote integration of the gained skills into everyday life. Outcomes measured will include cognitive processing speed, cognitive function on laboratory tests, and spontaneous performance of everyday activities with important cognitive components in daily life.

03

Conditions studied

  • ME/CFS
  • ME/CFS Following EBV-associated Infectious Mononucleosis
  • ME/CFS Following COVID-19
  • Chronic Fatigue
  • Chronic Fatigue Syndrome (CFS)
  • Brain Fog
  • Cognitive Impairment
  • Cognitive Dysfunction

Keywords

  • ME/CFS
  • Chronic Fatigue
  • Brain fog
  • Cognitive Impairment
  • Cognitive Dysfunction
  • post-viral syndrome
  • Cognitive Rehabilitation
  • CICT
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of ME/CFS that preceded cognitive complaints
  • mild or greater cognitive impairment
  • moderate or greater brain fog
  • some impairment in the performance of daily activities
  • ≥ 18 years, no upper limit if medically stable
  • reside in the community (as opposed to a hospital or skilled nursing facility)
  • able to travel to the laboratory on multiple occasions
  • has Internet service
  • has a personal computer, laptop, or tablet that can access the Internet
  • sufficiently fit, from both a physical and mental health perspective, to take part in the study
  • adequate sight and hearing to complete the UFOV test
  • adequate thinking skills, e.g., ability to follow directions and retain information to complete UFOV and CTAL, as marked by the judgement of the screener that the candidate is able to adequately complete the UFOV and CTAL
  • sufficient English proficiency (i.e., ability to speak, understand, read, and write to take part in study activities)

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment due to a developmental disability, psychiatric disorder, or substance abuse, or due to another type of brain injury, such as traumatic brain injury, stroke, or a progressive brain disease, such as Alzheimer's Dementia
  • current substance abuse disorder
  • diagnosis of postural orthostatic tachycardia syndrome (POTS) by a healthcare provider
  • prior cognitive processing speed training on DoubleDecision or a similar program
  • cannot tolerate taVNS
  • prior history of heart attack or other serious cardiac events
  • implanted medical device of any type
  • vasovagal syncope or history of fainting
  • history of seizures or epilepsy
  • temporomandibular Joint (TMJ) syndrome or other conditions that cause substantial jaw pain
  • history of peripheral nerve injury to the head, neck, or face
  • pregnant or breastfeeding
  • not able or willing to get an MRI scan
  • not able or willing to get a blood draw
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    CICT + taVNS

    Constraint-Induced Cognitive Therapy uses in-lab training on everyday activities with important cognitive components, along with the procedures designed to transfer improvements from the treatment setting to everyday life. This will be combined with computer-based processing speed training and non-invasive vagus nerve stimulation.

    Behavioral: Processing Speed Training · Behavioral: In-session Instrumental Activities of Daily Living Training · Behavioral: Transfer Package · Behavioral: Follow Up Phone Calls · Procedure: Trans-auricular Vagus Nerve Stimulation: High Intensity

  • Active comparator
    BFT + taVNS

    Brain Fitness Training involves in-lab training on relaxation, healthy nutrition, and healthy sleep with procedures designed to promote integration of these lifestyles into everyday life. This will be combined with computer-based reaction time training and non-invasive vagus nerve stimulation.

    Behavioral: Transfer Package · Behavioral: Follow Up Phone Calls · Behavioral: In-session Brain Health Training · Behavioral: Reaction Time Training · Procedure: Trans-auricular Vagus Nerve Stimulation: Low Intensity

Interventions

  • BehavioralProcessing Speed Training

    Speed of processing training involves trainer-guided practice of computer-based video "games." The games require the "player" to rapidly distinguish targets from decoys, which trains the player to process information from their senses quickly.

    Also known as: SOPT

  • BehavioralIn-session Instrumental Activities of Daily Living Training

    Participants will receive shaping on IADLs. Participants will receive training on everyday tasks with important cognitive components, in which the difficulty is increased in small steps over the course of treatment.

    Also known as: IADL Training

  • BehavioralTransfer Package

    The Transfer Package was designed to try to bridge the gap between what is trained in-session and what the participant does outside of treatment sessions. These components include negotiation of a behavioral contract with participants at the outset of treatment regarding the responsibilities of the participant, family caregivers, if available, and the treatment team, self-monitoring, assignment of "homework," review of homework by the trainer, and support of problem-solving by the participant.

    Also known as: TP

  • BehavioralFollow Up Phone Calls

    After completing training, participants will receive four weekly follow-up phone calls in the first month of training. The focus of the calls will incorporate the lessons learnt during treatment into daily life.

  • ProcedureTrans-auricular Vagus Nerve Stimulation: High Intensity

    The vagus nerve runs from the brain to the external ear, throat, chest, and abdomen and controls, among other functions, the rest and relax response, which supports learning and turns down inflammatory processes. The rest-and-relax response can be activated by electrically stimulating the vagus nerve. We will place electrodes on the external part of each ear and safely apply a microcurrent of at least 4 milliamps. Stimulation will be administered for 10 minutes near the start and midway point of each treatment session.

    Also known as: taVNS

  • BehavioralIn-session Brain Health Training

    Participants will receive training on healthy eating, sleeping, and relaxation techniques that have been shown to improve brain health.

  • BehavioralReaction Time Training

    Reaction time training involves trainer-guided practice of computer-based video "games." Several different games will be featured that train how rapidly "players" react to "threats" and train eye-hand coordination.

  • ProcedureTrans-auricular Vagus Nerve Stimulation: Low Intensity

    The vagus nerve run from the brain to the external ear, throat, chest, and abdomen and controls, among other functions, the rest and relax response, which supports learning and turns down inflammatory processes. The rest and relax response can be turned on by electrically stimulating the vagus nerve. We will place electrodes on the external part of each ear and safely apply a microcurrent of less than 4 milliamps. Stimulation will administered for 10 minutes near the start and midway point of each treatment session.

06

What researchers measure

Primary outcomes

  1. Canadian Occupational Performance Measure (COPM)

    The COPM is a standard, validated, trans-diagnostic, patient-centered structured interview commonly used to measure the real-world outcome of rehabilitation procedures that span both motor and cognitive functions after stroke. The Performance Scale assesses how well a participant performs five activities in their daily life, i.e., outside the lab, that are important to the participant. Activities, for this purpose, will be restricted to those with an important cognitive component ,i.e., IADL. The 10-point response scale ranges from 1 (not able to do the activity at all) to 10 (able to do the activity extremely well). Performance Scale scores from the participant will be the primary outcome.

    Time frame: Change from Day 30 to Day 60 (i.e., change from Pre- to Post-treatment)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jun 2027, 12 months after the start.

Of 73 non-industry interventional studies with no phase under Fatigue Syndrome, Chronic, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 78 studies reached it within 23 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2026
First posted
Apr 13, 2026
StartActual
Jun 23, 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2028
Last update
Oct 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Site contacts
Changed at 1 site. See the sites
Show the site
  • University of Alabama at Birmingham · Birmingham, United StatesContact n•••@uab.edu · •••9768→m•••@uab.edu · •••9768
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Site contacts Changed at 1 site. See the sites
    Show the site
    • University of Alabama at Birmingham · Birmingham, United StatesContact n•••@uab.edu · •••9768→m•••@uab.edu · •••9768
    + 2 other changes: verification date and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07523113
Collaborators
UAB College of Arts and Sciences & Department of Psychology, Posit Science Corporation
Responsible party
Gitendra Uswatte (Professor of Psychology and Physical Therapy, University of Alabama at Birmingham) — Principal investigator
First posted
Apr 13, 2026
Start date
Jun 23, 2026
Primary completion
Jun 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Oct 29, 2026

Study contacts

Madeline Rathz, BS
Contact
mgrathz@uab.edu
205-934-9768
Helen Bliss, BS
Contact
hmbliss@uab.edu
205-934-0433
Gitendra Uswatte, PhD
principal investigator · Professor of Psychology, University of Alabama at Birmingham

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion